A Randomized Phase II, Multi-Center, Open-Label, Trial of PR104 and Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer

Grants and Contracts Details

StatusFinished
Effective start/end date3/11/097/15/09

Funding

  • Proacta Inc